Career Enhancement Program
Career Enhancement Program
批准号:
10268748
负责人:
Jessie Villanueva
金额:
$8.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-03 至 2026-07-31
关键词:
Acral Lentiginous Malignant MelanomaAddressAwarenessBasal Cell CancerCancer CenterCancer Research ProjectCareer MobilityClinicalCutaneous MelanomaDepartment chairDevelopmentEnsureFacultyFinancial SupportFosteringFoundationsFundingFunding AgencyFutureGoalsGrantInstitutesLaboratoriesLeadershipMeasuresMelanoma CellMentorsMentorshipMinorityMonitorOralOutcomePaperPeer ReviewPennsylvaniaPoliciesPositioning AttributeProceduresProgress ReportsPublicationsPublishingResearchResearch PersonnelResearch Project GrantsResourcesSkin CancerSolidSquamous CellTalentsThe Wistar InstituteTrainingTraining SupportTranslational ResearchUnderrepresented MinorityUniversitiesWomanWorkanticancer researchcancer subtypescareercareer developmentdiversity and inclusionexpectationhealth disparityhigh standardinnovationinterestinvestigator trainingmeetingsmelanomamembernext generationprogramsrecruitresearch and developmentsuccesstranslational cancer researchtranslational research programtranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary – Career Enhancement Program
The goal of the Career Enhancement Program (CEP) is to recruit, train and retain a diverse pool of outstanding
early-career investigators who are committed to pursuing translational skin cancer research. The CEP will be led
by two established investigators with complementary expertise in basic (Dr. Villanueva) and clinical (Dr.
Schuchter) melanoma research. Both co-Directors are committed to training and mentoring of translational
investigators and have an established record of recruiting and supporting women and minorities. The CEP will
primarily assist junior faculty in their career development, but more established investigators interested in
refocusing their research efforts on melanoma/skin cancer could also be considered. Women and
underrepresented minorities will be strongly encouraged to participate. Likewise, projects aimed at addressing
health disparities and/or skin cancer subtypes more common in underrepresented minorities will be encouraged
and given special consideration. A team of clinicians, educators and researchers with broad expertise in
translational research will ensure implementation of the specific aims of this program. With the support of the
University of Pennsylvania, the Abramson Cancer Center and The Wistar Institute, the CEP will provide junior
faculty the resources and guidance needed to establish innovative and fully funded independent skin cancer
research programs and become future academic leaders. The CEP will provide awardees with two years of
financial support for translational research projects in skin cancer with potential promotion to full SPORE projects
or independent grant support. Awardees are required to actively participate in SPORE functions, use the SPORE
Core resources, and provide both formal written progress reports and oral presentations. We have established
high standards and expectations for the research mentors and a formalized program of long-term awardee
mentorship. The program measures success by resulting publications, funding, and ultimately career
advancement and national recognition. We have an outstanding talent pool of candidates and an effective
training and mentorship program that will result in an exceptional group of skin cancer researchers. Our SPORE
CEP has had an outstanding record recruiting and training investigators for careers in translational skin cancer research.
Our past CEP awardees have published 74 papers during the past cycle and have been highly successful in obtaining
peer reviewed funding from NCI and/or other funding agencies. In addition, all past awardees have transitioned from
young investigators into leading academic positions and remain in the skin cancer field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
-
批准号:10539830
-
项目类别:
-
资助金额:$52.28万
-
财政年份:2022
-
负责人:Jessie Villanueva
-
依托单位:
Career Enhancement Program
-
批准号:10480867
-
项目类别:
-
资助金额:$8.84万
-
财政年份:2021
-
负责人:Jessie Villanueva
-
依托单位:
Targeting TERT in Melanoma
-
批准号:10247101
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Administrative Core
-
批准号:10733193
-
项目类别:
-
资助金额:$7.92万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma
-
批准号:10733196
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2017
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8634081
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:9054086
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8826711
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:9246446
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
-
批准号:8488046
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2013
-
负责人:Jessie Villanueva
-
依托单位:
Animal Shared Resource
-
批准号:10360634
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1997
-
负责人:Jessie Villanueva
-
依托单位:
Animal Shared Resource
-
批准号:10570933
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1997
-
负责人:Jessie Villanueva
-
依托单位:
Animal Shared Resource
-
批准号:9917704
-
项目类别:
-
资助金额:$22.44万
-
财政年份:--
-
负责人:Jessie Villanueva
-
依托单位:
海外基金